NRIX CapEx to Revenue

Nurix Therapeutics Inc · CapEx to Revenue

NRIX logo

NRIX CapEx to Revenue

Current (TTM)1.35%
NRIX CapEx/Revenue (4.26% → 1.35%)
High-resolution chart · PNG

NRIX capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
16.673%
16.9994%
10.9122%
31.698%
19.0286%
25.5499%
5.3061%
4.2591%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.